RTW Biotech Opportunities Ltd (RTW) ORD NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
$1.56
$1.64
$1.64
195.00
$1.61
$1.56
$1.05
-17.44%
$0.02 (1.26%) Previous:
$0.02
484,677
n/a
USD
Price
-
Net Asset Value (NAV)
Performance
Not available for this stock.
Trust Basics
Benchmark: | Russell 2000 Biotech Growth |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 2.78% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £655m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £541m |
Shares in issue: | 335.71 million |
Legal structure | Closed Ended Investment Company |
Domicile: | Guernsey |
ISIN | GG00BKTRRM22 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 195.00 |
---|---|
Latest actual NAV: | n/a |
Latest actual NAV date: | n/a |
Premium/Discount: | -17.44% |
12m average Premium/Discount: | -25.21% |
NAV frequency: | Monthly |
Security | Weight |
---|---|
Rocket | 10.31% |
Ji Xing | 7.75% |
Equity Swaps | 5.91% |
Rtw Royalty Holdings 2 | 4.59% |
Prometheus Biosciences | 4.19% |
Immunocore | 3.81% |
Avidity | 3.22% |
Beta Bionics | 1.80% |
Ni Kang | 1.38% |
Alcyone | 1.28% |
Top 10 sectors currently unavailable.
Country | Weight |
---|---|
United States | 5.05% |
India | 1.20% |
Ireland | 0.97% |
Key Dates
Launch date: | 29 October 2019 |
---|---|
Financial year end: | December |
Next AGM: | May 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.